EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS053-39070 
Organism
Homo sapiens 
Tissue/cell
Foreskin_keratinocyte 
Coordinate
chr8:99103260-99104530 
TF binding sites/motifs
Number: 25             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr8:99104221-99104239CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr8:99104225-99104243CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr8:99104229-99104247CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr8:99104233-99104251CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr8:99104115-99104133CTTTCTTTCTTTCCTTTC-6.03
EWSR1-FLI1MA0149.1chr8:99104139-99104157TCTTTCTTCCTTTCTTTC-6.22
EWSR1-FLI1MA0149.1chr8:99104143-99104161TCTTCCTTTCTTTCTTTC-6.22
EWSR1-FLI1MA0149.1chr8:99104155-99104173TCTTTCTTCCTTTCTTTC-6.22
EWSR1-FLI1MA0149.1chr8:99104159-99104177TCTTCCTTTCTTTCTTTC-6.22
EWSR1-FLI1MA0149.1chr8:99104119-99104137CTTTCTTTCCTTTCTTTC-6.33
EWSR1-FLI1MA0149.1chr8:99104123-99104141CTTTCCTTTCTTTCTTTC-6.34
EWSR1-FLI1MA0149.1chr8:99104147-99104165CCTTTCTTTCTTTCTTCC-6.67
EWSR1-FLI1MA0149.1chr8:99104217-99104235CTCCCCTTCCTTCCTTCC-7.43
EWSR1-FLI1MA0149.1chr8:99104237-99104255CCTTCCTTCCTTCCTTTC-9.6
IRF1MA0050.2chr8:99104189-99104210TTTTTCTTTCTTTTTCTTCTC+6.08
IRF1MA0050.2chr8:99104040-99104061ACTTTCTTTTTCTTTCTTTTT+6.17
IRF1MA0050.2chr8:99104046-99104067TTTTTCTTTCTTTTTCTTTTT+7.26
ZNF263MA0528.1chr8:99104233-99104254CCTTCCTTCCTTCCTTCCTTT-6.16
ZNF263MA0528.1chr8:99104213-99104234CTCTCTCCCCTTCCTTCCTTC-6.43
ZNF263MA0528.1chr8:99104217-99104238CTCCCCTTCCTTCCTTCCTTC-6.58
ZNF263MA0528.1chr8:99104209-99104230CTCTCTCTCTCCCCTTCCTTC-6.74
ZNF263MA0528.1chr8:99104221-99104242CCTTCCTTCCTTCCTTCCTTC-6.94
ZNF263MA0528.1chr8:99104225-99104246CCTTCCTTCCTTCCTTCCTTC-6.94
ZNF263MA0528.1chr8:99104229-99104250CCTTCCTTCCTTCCTTCCTTC-6.94
ZfxMA0146.2chr8:99103407-99103421CCCGCCTCGGCCTC+6.01
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr89910372899103940
chr89910360099103790
Enhancer Sequence
GTTCAAGCGA TTCTCCCGCC TCAGCCTCCT GAGTAGCTGG GACTACAGGC GCACACCACC 60
ATGCCCGGCT AGTTTTTGTA TTTTTAGTAG AGACGGGGTT TCACCACATT GGCCAGGCTG 120
GTCTCCAGCT CCTGACCTCA TGATCCACCC GCCTCGGCCT CCCAAAGTGC CGGGATTACA 180
GGCATGAGCC ACCATGTCTG GCCAATTCTT TCATTTATTA ACTCAGCATT TTTTGGCATG 240
CCTAAACATA TGCTAGGTGC TGAGATGCAG ACTGAGGAAG AGATAGTCTC TGTCCTCAAG 300
GGGCTCACTG TCTAGTGTGG GAAGGCAGGA TGTGCGTGCA TCACCATAGT CTGTTGTGGG 360
AACTGCTTTC CTAAGAATGT GTAAGAAGGG CCCTGGGAAC AACTTGGGAG AGGCAAATAA 420
AAGCAGGTAG TTTTTACATC AGGATTGGCA AACTCAAAAG TCTTTAGGCC TAGGATACTG 480
AAAATGAGTG AGGTGAAGGA CACATGTCAT ACTGTGGGAG CCCAGGGGAC CTTGGCAAAC 540
AGGAGAGCAC AGCCTTGTCA AAAGAGGAAG CTCCGCACAG CTCCAGCCAT GGAACTAGGG 600
CCAATGTTGC CAAAGCCAAC TTCTCAGGGA AACAGGGTTT CCTGCAAGTG TGTGCAATGT 660
CCAGACTTGT TAGTGTTGGC TGTCTGTAAA TGTTTAACGA TTGTTTTTAA ACACATAATG 720
GCCAAGCCAG ACAGGTTTAG GGGCACCCCT GGACCACCCT TTGATTTAGA TACAAATTAG 780
ACTTTCTTTT TCTTTCTTTT TCTTTTTCTT TCTTTCTTTC TTTCTTTCTT TCTTTCTTTC 840
TTTCTTTCTT TCTTTCTTTC TTTCTTTCCT TTCTTTCTTT CTTTCTTCCT TTCTTTCTTT 900
CTTCCTTTCT TTCTTTCTTC TTTCTTTCTT TTTTCTTTCT TTTTCTTCTC TCTCTCTCTC 960
CCCTTCCTTC CTTCCTTCCT TCCTTCCTTC CTTTCGAGAC AAGATCTTCA AGCTGGAGTG 1020
CAGTGATGCA ATCACAGCTC ACTATAATCT CCAACTCCTG GACTGAAGGG ATCCTCTTGC 1080
CCCAGCTCTC AAGTAGCTAG GACTACAGGA ATGTGCCACC ATGCCTGGCT AATTTTTTTT 1140
TCTTTTAAAA AATTATTACT TTTGAGACAG AGTCTTGCTC TGTTACTCAG GCTGGAGTGC 1200
AGTGGTATTC TTAGCTCATT GTAACTTCTG CCTCCCAGCT CAATCCATTC TCCCTCCTCG 1260
GCCTCCTGAG 1270